Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply

Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply

•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical epidemiology 2024-07, Vol.171, p.111374, Article 111374
Hauptverfasser: Kou, Roger, Mbuagbaw, Lawrence
Format: Artikel
Sprache:eng
Schlagworte:
Authorship
COVID-19
COVID-19 vaccines
Ethnicity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.
ISSN:0895-4356
1878-5921
1878-5921
DOI:10.1016/j.jclinepi.2024.111374